Find information on thousands of medical conditions and prescription drugs.

Exemestane

Exemestane (Trade name: Aromasin®) is an oral steroidal aromatase inhibitor used in the treatment of hormonally-responsive breast cancer.

Estrogens are produced by the conversion of androgens through the activity of the aromatase enzyme. Exemestant selectively targets and irreversibly binds to the aromatase enzyme, thereby inhibiting the production of estrogen.

Home

E-Base

Edecrin

Effexor

Elavil

Elidel

Eligard

Elitek

Elmiron

Elspar

Emtriva

Endep

Enulose

Epi-pen

Epinephrine

Epirubicin

Epitol

Epivir

Epogen

Eryc

Eryped

Esgic

Esmolol

Estrace

Estring

Estrone

Evista

Exelon

Exemestane

Hexal Australia

Read more at Wikipedia.org

• [List your site here Free!]


	Aromatase Inhibitors (Milestones in Drug Therapy) (Milestones in Drug Therapy) $155.48	Exemestane after tamoxifen improves disease-free survival; postmenopausal women with breast cancer.(Women's Health) : An article from: Family Practice News $5.95

	Exemestane beats Tamoxifen for advanced breast cancer.(Women's Health) : An article from: Internal Medicine News $5.95


Postmenopausal women with breast CA: exemestane after tamoxifen increases survival Switching to exemestane therapy after 2-3 years of tamoxifen treatment improves disease-free survival in postmenopausal women with breast cancer, according ... From OB/GYN News, 4/15/04 by Mary Ann Moon

Aromasin approved as adjuvant Aromasin (exemestane tablets) is approved as an adjuvant treatment for post-menopausal women with estrogen receptor-positive breast cancer who have received ... From OB/GYN News, 12/1/05

Tamoxifen alone discouraged as adjuvant Tx HOLLYWOOD, FLA. -- An aromatase inhibitor, either alone or after tamoxifen therapy, is better than tamoxifen alone for the long-term prevention of breast ... From OB/GYN News, 5/1/05 by Diana Mahoney

Tamoxifen-aromatase inhibitor combo improves Ca outcomes SAN ANTONIO -- Switching postmenopausal breast cancer patients to an aromatase inhibitor following 2-3 years of adjuvant tamoxifen results in markedly ... From OB/GYN News, 2/1/05 by Bruce Jancin

ASCO: aromatase inhibitor can replace tamoxifen Postmenopausal women with hormone receptor-positive breast cancer can take an aromatase inhibitor instead of tamoxifen as adjuvant therapy, the American ... From OB/GYN News, 12/15/04 by Timothy F. Kirn

Off-label use: aromatase inhibitors show promise in fertility Tx LAS VEGAS -- Aromatase inhibitors may be the answer for women in whom clomiphene fails to induce ovulation, Dr. Robert F. Casper said at the Fifth World ... From OB/GYN News, 9/1/04 by Norra MacReady

Face to face with mental health services To get a broader feel for the experiences of mental health service users, Mental Health Nursing put out an appeal for individuals to respond to three questions about their experiences and expectation From Mental Health Nursing, 9/1/04

Why get a second pathology opinion for breast cancer: an interview Of all the tests given to a woman newly diagnosed with breast cancer, one is crucial in determining her treatment plan. It measures the tumor's "hormone ... From Healthfacts, 9/1/04

Home

Contact

Resources

Exchange Links

ebay